Download PDF
CC BY 4.0 · Aorta (Stamford) 2013; 01(01): 23-39
DOI: 10.12945/j.aorta.2013.13.006
Original Research Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

New Insights Into Aortic Diseases

A Report From the Third International Meeting on Aortic Diseases (IMAD3)
Helena Kuivaniemi
1   Sigfried and Janet Weis Center for Research, Geisinger Clinic, Danville, Pennsylvania
,
Natzi Sakalihasan
2   Cardiovascular Surgery Departments, University Hospital of Liège, CHU, Liège, Belgium
,
Frank A. Lederle
4   Minneapolis Center for Epidemiological and Clinical Research, Department of Medicine (III-0), VA Medical Center, Minneapolis, Minnesota
,
Gregory T. Jones
5   Surgery Department, University of Otago, Dunedin, New Zealand
,
Jean-Olivier Defraigne
2   Cardiovascular Surgery Departments, University Hospital of Liège, CHU, Liège, Belgium
,
Nicos Labropoulos
6   Department of Surgery, Stony Brook University Medical Center, Stony Brook, New York
,
Victor Legrand
3   Cardiology Departments, University Hospital of Liège, CHU, Liège, Belgium
,
Jean-Baptiste Michel
7   INSERM U698, Paris, France
,
Christoph Nienaber
8   Heart Center Rostock, University of Rostock, Rostock, Germany
,
Marc A. Radermecker
2   Cardiovascular Surgery Departments, University Hospital of Liège, CHU, Liège, Belgium
,
John A. Elefteriades
9   Aortic Institute, Yale University School of Medicine, New Haven, Connecticut
› Author Affiliations
Further Information

Publication History

18 January 2013

08 March 2013

Publication Date:
28 September 2018 (online)

Also available at
   Permissions and Reprints

Abstract

The current state of research and treatment on aortic diseases was discussed in the “3rd International Meeting on Aortic Diseases” (IMAD3) held on October 4–6, 2012, in Liège, Belgium. The 3-day meeting covered a wide range of topics related to thoracic aortic aneurysms and dissections, abdominal aortic aneurysms, and valvular diseases. It brought together clinicians and basic scientists and provided an excellent opportunity to discuss future collaborative research projects for genetic, genomics, and biomarker studies, as well as clinical trials. Although great progress has been made in the past few years, there are still a large number of unsolved questions about aortic diseases. Obtaining answers to the key questions will require innovative, interdisciplinary approaches that integrate information from epidemiological, genetic, molecular biology, and bioengineering studies on humans and animal models. It is more evident than ever that multicenter collaborations are needed to accomplish these goals.

Key Words

Aortic aneurysm - Valvular disease - Epidemiology - Genetics - Surgical repair
 

  • References

  • 1 Kuivaniemi H, Tromp G, Carey DJ, Elmore JR. The molecular biology and genetics of aneurysms. In: Homeister JW, Willis MS. , eds. Molecular and Translational Vascular Medicine. New York, NY: Springer Science+Business Media; 2012: 3-33
    CrossrefGoogle Scholar
  • 2 De Paepe A, Malfait F. The Ehlers-Danlos syndrome, a disorder with many faces. Clin Genet 2012; 82: 1-11 . 10.1111/j.1399–0004.2012.01858.x
    CrossrefPubMedGoogle Scholar
  • 3 Doyle AJ, Doyle JJ, Bessling SL, Maragh S, Lindsay ME, Schepers D. , et al. Mutations in the TGF-beta repressor SKI cause Shprintzen-Goldberg syndrome with aortic aneurysm. Nat Genet 2012; 44: 1249-1254 . 10.1038/ng.2421
    CrossrefPubMedGoogle Scholar
  • 4 Holm TM, Habashi JP, Doyle JJ, Bedja D, Chen Y, van Erp C. , et al. Noncanonical TGFβ signaling contributes to aortic aneurysm progression in Marfan syndrome mice. Science 2011; 332: 358-361 . 10.1126/science.1192149
    CrossrefPubMedGoogle Scholar
  • 5 Kappanayil M, Nampoothiri S, Kannan R, Renard M, Coucke P, Malfait F. , et al. Characterization of a distinct lethal arteriopathy syndrome in twenty-two infants associated with an identical, novel mutation in FBLN4 gene, confirms fibulin-4 as a critical determinant of human vascular elastogenesis. Orphanet J Rare Dis 2012; 7: 61 . 10.1186/1750–1172-7–61
    CrossrefPubMedGoogle Scholar
  • 6 Lindsay ME, Dietz HC. Lessons on the pathogenesis of aneurysm from heritable conditions. Nature 2011; 473: 308-316 . 10.1038/nature10145
    PubMedGoogle Scholar
  • 7 Lindsay ME, Schepers D, Bolar NA, Doyle JJ, Gallo E, Fert-Bober J. , et al. Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm. Nat Genet 2012; 44: 922-927 . 10.1038/ng.2349
    CrossrefPubMedGoogle Scholar
  • 8 Moberg K, De Nobele S, Devos D, Goetghebeur E, Segers P, Trachet B. , et al. The Ghent Marfan Trial: A randomized, double-blind placebo controlled trial with losartan in Marfan patients treated with beta-blockers. Int J Cardiol 2012; 157: 354-358 . 10.1016/j.ijcard.2010.12.070
    CrossrefPubMedGoogle Scholar
  • 9 van de Laar IM, van der Linde D, Oei EH, Bos PK, Bessems JH, Bierma-Zeinstra SM. , et al. Phenotypic spectrum of the SMAD3-related aneurysms-osteoarthritis syndrome. J Med Genet 2012; 49: 47-57 . 10.1136/jmedgenet-2011–100382
    CrossrefPubMedGoogle Scholar
  • 10 van der Linde D, van de Laar IM, Bertoli-Avella AM, Oldenburg RA, Bekkers JA, Mattace-Raso FU. , et al. Aggressive cardiovascular phenotype of aneurysms-osteoarthritis syndrome caused by pathogenic SMAD3 variants. J Am Coll Cardiol 2012; 60: 397-403 . 10.1016/j.jacc.2011.12.052
    CrossrefPubMedGoogle Scholar
  • 11 Carmignac V, Thevenon J, Ades L, Callewaert B, Julia S, Thauvin-Robinet C. , et al. In-frame mutations in exon 1 of SKI cause dominant Shprintzen-Goldberg syndrome. Am J Hum Genet 2012; 91: 950-957 . 10.1016/j.ajhg.2012.10.002
    CrossrefPubMedGoogle Scholar
  • 12 Milewicz DM, Østergaard JR, Ala-Kokko LM, Khan N, Grange DK, Mendoza-Londono R. , et al. De novo ACTA2 mutation causes a novel syndrome of multisystemic smooth muscle dysfunction. Am J Med Genet A 2010; 152A: 2437-2443 . 10.1002/ajmg.a.33657
    CrossrefPubMedGoogle Scholar
  • 13 Milewicz DM, Guo DC, Tran-Fadulu V, Lafont AL, Papke CL, Inamoto S. , et al. Genetic basis of thoracic aortic aneurysms and dissections: Focus on smooth muscle cell contractile dysfunction. Annu Rev Genomics Hum Genet 2008; 9: 283-302 . 10.1146/annurev.genom.8.080706.092303
    CrossrefPubMedGoogle Scholar
  • 14 Guo G, Munoz-Garcia B, Ott CE, Grunhagen J, Mousa SA, Pletschacher A. , et al. Antagonism of GxxPG fragments ameliorates manifestations of aortic disease in Marfan syndrome mice. Hum Mol Genet 2012; 22: 433-443
    PubMedGoogle Scholar
  • 15 De Backer JF, Devos D, Segers P, Matthys D, Francois K, Gillebert TC. , et al. Primary impairment of left ventricular function in Marfan syndrome. Int J Cardiol 2006; 112: 353-358 . 10.1016/j.ijcard.2005.10.010
    CrossrefPubMedGoogle Scholar
  • 16 Ong KT, Perdu J, De Backer J, Bozec E, Collignon P, Emmerich J. , et al. Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial. Lancet 2010; 376: 1476-1484 . 10.1016/S0140–6736(10)60960–9
    CrossrefPubMedGoogle Scholar
  • 17 Achneck H, Modi B, Shaw C, Rizzo J, Albornoz G, Fusco D, Elefteriades JA. Ascending thoracic aneurysms are associated with decreased systemic atherosclerosis. Chest 2005; 128: 1580-1586 . 10.1378/chest.128.3.1580
    CrossrefPubMedGoogle Scholar
  • 18 Hung A, Zafar M, Mukherjee S, Tranquilli M, Scoutt LM, Elefteriades JA. Carotid intima-media thickness provides evidence that ascending aortic aneurysm protects against systemic atherosclerosis. Cardiology 2012; 123: 71-77 . 10.1159/000341234
    CrossrefPubMedGoogle Scholar
  • 19 Grainger DJ. TGF-beta and atherosclerosis in man. Cardiovasc Res 2007; 74: 213-222 . 10.1016/j.cardiores.2007.02.022
    CrossrefPubMedGoogle Scholar
  • 20 Trimarchi S, Sangiorgi G, Sang X, Rampoldi V, Suzuki T, Eagle KA, Elefteriades JA. In search of blood tests for thoracic aortic diseases. Ann Thorac Surg 2010; 90: 1735-1742 . 10.1016/j.athoracsur.2010.04.111
    CrossrefPubMedGoogle Scholar
  • 21 Wang Y, Barbacioru CC, Shiffman D, Balasubramanian S, Iakoubova O, Tranquilli M. , et al. Gene expression signature in peripheral blood detects thoracic aortic aneurysm. PLoS One 2007; 2: e1050 . 10.1371/journal.pone.0001050
    CrossrefPubMedGoogle Scholar
  • 22 Bonser RS, Ranasinghe AM, Loubani M, Evans JD, Thalji NM, Bachet JE. , et al. Evidence, lack of evidence, controversy, and debate in the provision and performance of the surgery of acute type A aortic dissection. J Am Coll Cardiol 2011; 58: 2455-2474 . 10.1016/j.jacc.2011.06.067
    CrossrefPubMedGoogle Scholar
  • 23 Elefteriades JA. What is the best method for brain protection in surgery of the aortic arch? Straight DHCA. Cardiol Clin 2010; 28: 381-387 . 10.1016/j.ccl.2010.02.004
    CrossrefPubMedGoogle Scholar
  • 24 Shann KG, Likosky DS, Murkin JM, Baker RA, Baribeau YR, DeFoe GR. , et al. An evidence-based review of the practice of cardiopulmonary bypass in adults: A focus on neurologic injury, glycemic control, hemodilution, and the inflammatory response. J Thorac Cardiovasc Surg 2006; 132: 283-290 . 10.1016/j.jtcvs.2006.03.027
    CrossrefPubMedGoogle Scholar
  • 25 Rahe-Meyer N. Fibrinogen concentrate in the treatment of severe bleeding after aortic aneurysm graft surgery. Thromb Resm 2011; 128 (suppl 1) S17-S19
    PubMedGoogle Scholar
  • 26 Gomez D, Al Haj Zen A, Borges LF, Philippe M, Gutierrez PS, Jondeau G. , et al. Syndromic and non-syndromic aneurysms of the human ascending aorta share activation of the Smad2 pathway. J Pathol 2009; 218: 131-142 . 10.1002/path.2516
    CrossrefPubMedGoogle Scholar
  • 27 Gomez D, Coyet A, Ollivier V, Jeunemaitre X, Jondeau G, Michel JB, Vranckx R. Epigenetic control of vascular smooth muscle cells in Marfan and non-Marfan thoracic aortic aneurysms. Cardiovasc Res 2011; 89: 446-456 . 10.1093/cvr/cvq291
    CrossrefPubMedGoogle Scholar
  • 28 Jondeau G, Michel JB, Boileau C. The translational science of Marfan syndrome. Heart 2011; 97: 1206-1214 . 10.1136/hrt.2010.212100
    CrossrefPubMedGoogle Scholar
  • 29 Michel JB, Thaunat O, Houard X, Meilhac O, Caligiuri G, Nicoletti A. Topological determinants and consequences of adventitial responses to arterial wall injury. Arterioscler Thromb Vasc Biol 2007; 27: 1259-1268 . 10.1161/ATVBAHA.106.137851
    CrossrefPubMedGoogle Scholar
  • 30 Meilhac O, Ho-Tin-Noe B, Houard X, Philippe M, Michel JB, Angles-Cano E. Pericellular plasmin induces smooth muscle cell anoikis. FASEB J 2003; 17: 1301-1303
    CrossrefPubMedGoogle Scholar
  • 31 Borges LF, Gomez D, Quintana M, Touat Z, Jondeau G, Leclercq A. , et al. Fibrinolytic activity is associated with presence of cystic medial degeneration in aneurysms of the ascending aorta. Histopathology 2010; 57: 917-932 . 10.1111/j.1365–2559.2010.03719.x
    CrossrefPubMedGoogle Scholar
  • 32 Anjum A, von Allmen R, Greenhalgh R, Powell JT. Explaining the decrease in mortality from abdominal aortic aneurysm rupture. Br J Surg 2012; 99: 637-645 . 10.1002/bjs.8698
    CrossrefPubMedGoogle Scholar
  • 33 Villard C, Wagsater D, Swedenborg J, Eriksson P, Hultgren R. Biomarkers for abdominal aortic aneurysms from a sex perspective. Gend Med 2012; 9: 259-266 .e252.
    CrossrefPubMedGoogle Scholar
  • 34 Hultgren R, Larsson E, Wahlgren CM, Swedenborg J. Female and elderly abdominal aortic aneurysm patients more commonly have concurrent thoracic aortic aneurysm. Ann Vasc Surg 2012; 26: 918-923 . 10.1016/j.avsg.2012.01.023
    CrossrefPubMedGoogle Scholar
  • 35 Dahabreh IJ, Kent DM. Index event bias as an explanation for the paradoxes of recurrence risk research. JAMA 2011; 305: 822-823 . 10.1001/jama.2011.163
    CrossrefPubMedGoogle Scholar
  • 36 Norman PE, Muller J, Golledge J. The cardiovascular and prognostic significance of the infrarenal aortic diameter. J Vasc Surg 2011; 54: 1817-1820 . 10.1016/j.jvs.2011.07.048
    CrossrefPubMedGoogle Scholar
  • 37 Wahlgren CM, Larsson E, Magnusson PK, Hultgren R, Swedenborg J. Genetic and environmental contributions to abdominal aortic aneurysm development in a twin population. J Vasc Surg 2010; 51: 3-7 . 10.1016/j.jvs.2009.08.036
    CrossrefPubMedGoogle Scholar
  • 38 Sandford RM, Bown MJ, London NJ, Sayers RD. The genetic basis of abdominal aortic aneurysms: A review. Eur J Vasc Endovasc Surg 2007; 33: 381-390 . 10.1016/j.ejvs.2006.10.025
    CrossrefPubMedGoogle Scholar
  • 39 Hinterseher I, Tromp G, Kuivaniemi H. Genes and abdominal aortic aneurysm. Ann Vasc Surg 2011; 25: 388-412 . 10.1016/j.avsg.2010.09.004
    CrossrefPubMedGoogle Scholar
  • 40 Elmore JR, Obmann MA, Kuivaniemi H, Tromp G, Gerhard GS, Franklin DP. , et al. Identification of a genetic variant associated with abdominal aortic aneurysms on chromosome 3p12.3 by genome wide association. J Vasc Surg 2009; 49: 1525-1531 . 10.1016/j.jvs.2009.01.041
    CrossrefPubMedGoogle Scholar
  • 41 Bown MJ, Jones GT, Harrison SC, Wright BJ, Bumpstead S, Baas AF. , et al. Abdominal aortic aneurysm is associated with a variant in low-density lipoprotein receptor-related protein 1. Am J Hum Genet 2011; 89: 619-627 . 10.1016/j.ajhg.2011.10.002
    CrossrefPubMedGoogle Scholar
  • 42 Gretarsdottir S, Baas AF, Thorleifsson G, Holm H, den Heijer M, de Vries JP. , et al. Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm. Nat Genet 2010; 42: 692-697 . 10.1038/ng.622
    CrossrefPubMedGoogle Scholar
  • 43 Helgadottir A, Thorleifsson G, Magnusson KP, Gretarsdottir S, Steinthorsdottir V, Manolescu A. , et al. The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet 2008; 40: 217-224 . 10.1038/ng.72
    CrossrefPubMedGoogle Scholar
  • 44 Harrison SC, Smith AJ, Jones GT, Swerdlow DI, Rampuri R, Bown MJ. , et al. Interleukin-6 receptor pathways in abdominal aortic aneurysm. Eur Heart J. Published online before print October 30, 2012. 10.1093/eurheartj/ehs354. Available at: http://eurheartj.oxfordjournals.org/content/early/2012/10/30/eurheartj.ehs354.long . Accessed April 3, 2013.
    PubMedGoogle Scholar
  • 45 Helgadottir A, Gretarsdottir S, Thorleifsson G, Holm H, Patel RS, Gudnason T. , et al. Apolipoprotein(a) genetic sequence variants associated with systemic atherosclerosis and coronary atherosclerotic burden but not with venous thromboembolism. J Am Coll Cardiol 2012; 60: 722-729 . 10.1016/j.jacc.2012.01.078
    CrossrefPubMedGoogle Scholar
  • 46 Schunkert H, Konig IR, Kathiresan S, Reilly MP, Assimes TL, Holm H. , et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 2011; 6: 333-338
    PubMedGoogle Scholar
  • 47 Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M. , et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010; 466: 707-713 . 10.1038/nature09270
    PubMedGoogle Scholar
  • 48 Wang K, Li M, Hakonarson H. Analysing biological pathways in genome-wide association studies. Nat Rev Genet 2010; 11: 843-854 . 10.1038/nrg2884
    CrossrefPubMedGoogle Scholar
  • 49 Thorgeirsson TE, Geller F, Sulem P, Rafnar T, Wiste A, Magnusson KP. , et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 2008; 452: 638-642 . 10.1038/nature06846
    PubMedGoogle Scholar
  • 50 McCarty CA, Chisholm RL, Chute CG, Kullo IJ, Jarvik GP, Larson EB. , et al. The eMERGE Network: A consortium of biorepositories linked to electronic medical records data for conducting genomic studies. BMC Med Genomics 2011; 4: 13 . 10.1186/1755–8794-4–13
    CrossrefPubMedGoogle Scholar
  • 51 Folkersen L, van't Hooft F, Chernogubova E, Agardh HE, Hansson GK, Hedin U. , et al. Association of genetic risk variants with expression of proximal genes identifies novel susceptibility genes for cardiovascular disease. Circ Cardiovasc Genet 2010; 3: 365-373 . 10.1161/CIRCGENETICS.110.948935
    CrossrefPubMedGoogle Scholar
  • 52 Hinterseher I, Erdman R, Donoso LA, Vrabec TR, Schworer CM, Lillvis JH. , et al. Role of complement cascade in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2011; 31: 1653-1660 . 10.1161/ATVBAHA.111.227652
    CrossrefPubMedGoogle Scholar
  • 53 Hinterseher I, Erdman R, Elmore JR, Stahl E, Pahl MC, Derr K. , et al. Novel pathways in the pathobiology of human abdominal aortic aneurysms. Pathobiology 2013; 80: 1-10 . 10.1159/000339303
    CrossrefPubMedGoogle Scholar
  • 54 Michel JB, Martin-Ventura JL, Egido J, Sakalihasan N, Treska V, Lindholt J. , et al. Novel aspects of the pathogenesis of aneurysms of the abdominal aorta in humans. Cardiovasc Res 2011; 90: 18-27 . 10.1093/cvr/cvq337
    CrossrefPubMedGoogle Scholar
  • 55 Pincemail J, Defraigne JO, Cheramy-Bien JP, Dardenne N, Donneau AF, Albert A. , et al. On the potential increase of the oxidative stress status in patients with abdominal aortic aneurysm. Redox Rep 2012; 17: 139-144 . 10.1179/1351000212Y.0000000012
    CrossrefPubMedGoogle Scholar
  • 56 Ciborowski M, Teul J, Martin-Ventura JL, Egido J, Barbas C. Metabolomics with LC-QTOF-MS permits the prediction of disease stage in aortic abdominal aneurysm based on plasma metabolic fingerprint. PLoS One 2012; 7: e31982 . 10.1371/journal.pone.0031982
    CrossrefPubMedGoogle Scholar
  • 57 Martinez-Pinna R, Ramos-Mozo P, Madrigal-Matute J, Blanco-Colio LM, Lopez JA, Calvo E. , et al. Identification of peroxiredoxin-1 as a novel biomarker of abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 2011; 31: 935-943 . 10.1161/ATVBAHA.110.214429
    CrossrefPubMedGoogle Scholar
  • 58 Ramos-Mozo P, Madrigal-Matute J, Martinez-Pinna R, Blanco-Colio LM, Lopez JA, Camafeita E. , et al. Proteomic analysis of polymorphonuclear neutrophils identifies catalase as a novel biomarker of abdominal aortic aneurysm: Potential implication of oxidative stress in abdominal aortic aneurysm progression. Arterioscler Thromb Vasc Biol 2011; 31: 3011-3019 . 10.1161/ATVBAHA.111.237537
    CrossrefPubMedGoogle Scholar
  • 59 Ramos-Mozo P, Madrigal-Matute J, Vega de Ceniga M, Blanco-Colio LM, Meilhac O, Feldman L. , et al. Increased plasma levels of NGAL, a marker of neutrophil activation, in patients with abdominal aortic aneurysm. Atherosclerosis 2012; 220: 552-556 . 10.1016/j.atherosclerosis.2011.11.023
    CrossrefPubMedGoogle Scholar
  • 60 Ramos-Mozo P, Rodriguez C, Pastor-Vargas C, Blanco-Colio LM, Martinez-Gonzalez J, Meilhac O. , et al. Plasma profiling by a protein array approach identifies IGFBP-1 as a novel biomarker of abdominal aortic aneurysm. Atherosclerosis 2012; 221: 544-550 . 10.1016/j.atherosclerosis.2012.01.009
    CrossrefPubMedGoogle Scholar
  • 61 Ruperez FJ, Ramos-Mozo P, Teul J, Martinez-Pinna R, Garcia A, Malet-Martino M. , et al. Metabolomic study of plasma of patients with abdominal aortic aneurysm. Anal Bioanal Chem 2012; 403: 1651-1660 . 10.1007/s00216–012-5982-y
    CrossrefPubMedGoogle Scholar
  • 62 van der Meij E, Koning GG, Vriens PW, Peeter MF, Meijer CA, Kortekaas KE. , et al. A clinical evaluation of statin pleiotropy: Statins selectively and dose-dependently reduce vascular inflammation. PLoS One 2013; 8: e53882 . 10.1371/journal.pone.0053882
    CrossrefPubMedGoogle Scholar
  • 63 Onoda M, Yoshimura K, Aoki H, Ikeda Y, Morikage N, Furutani A. , et al. Lysyl oxidase resolves inflammation by reducing monocyte chemoattractant protein-1 in abdominal aortic aneurysm. Atherosclerosis 2010; 208: 366-369 . 10.1016/j.atherosclerosis.2009.07.036
    CrossrefPubMedGoogle Scholar
  • 64 Pirianov G, Torsney E, Howe F, Cockerill GW. Rosiglitazone negatively regulates c-Jun N-terminal kinase and toll-like receptor 4 proinflammatory signalling during initiation of experimental aortic aneurysms. Atherosclerosis 2012; 225: 69-75 . 10.1016/j.atherosclerosis.2012.07.034
    CrossrefPubMedGoogle Scholar
  • 65 Torsney E, Pirianov G, Charolidi N, Shoreim A, Gaze D, Petrova S. , et al. Elevation of plasma high-density lipoproteins inhibits development of experimental abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2012; 32: 2678-2686 . 10.1161/ATVBAHA.112.00009
    CrossrefPubMedGoogle Scholar
  • 66 Lillvis JH, Erdman R, Schworer CM, Golden A, Derr K, Gatalica Z. , et al. Regional expression of HOXA4 along the aorta and its potential role in human abdominal aortic aneurysms. BMC Physiol 2011; 11: 9 . 10.1186/1472–6793-11–9
    CrossrefPubMedGoogle Scholar
  • 67 Pahl MC, Derr K, Gabel G, Hinterseher I, Elmore JR, Schworer CM. , et al. MicroRNA expression signature in human abdominal aortic aneurysms. BMC Med Genomics 2012; 5: 25 . 10.1186/1755–8794-5–25
    CrossrefPubMedGoogle Scholar
  • 68 Nischan J, Gatalica Z, Curtis M, Lenk GM, Tromp G, Kuivaniemi H. Binding sites for ETS family of transcription factors dominate the promoter regions of differentially expressed genes in abdominal aortic aneurysms. Circ Cardiovasc Genet 2009; 2: 565-572 . 10.1161/CIRCGENETICS.108.843854
    CrossrefPubMedGoogle Scholar
  • 69 Takagi H, Yamamoto H, Iwata K, Goto S, Umemoto T, Group A. Effects of statin therapy on abdominal aortic aneurysm growth: A meta-analysis and meta-regression of observational comparative studies. Eur J Vasc Endovasc Surg 2012; 44: 287-292 . 10.1016/j.ejvs.2012.06.021
    CrossrefPubMedGoogle Scholar
  • 70 Twine CP, Williams IM. Systematic review and meta-analysis of the effects of statin therapy on abdominal aortic aneurysms. Br J Surg 2011; 98: 346-353 . 10.1002/bjs.7343
    CrossrefPubMedGoogle Scholar
  • 71 Vega de Ceniga M. Commentary on “Effects of statin therapy on abdominal aortic aneurysm growth: A meta-analysis and meta-regression of observational comparative studies.”. Eur J Vasc Endovasc Surg 2012; 44: 293 . 10.1016/j.ejvs.2012.06.024
    CrossrefPubMedGoogle Scholar
  • 72 Rughani G, Robertson L, Clarke M. Medical treatment for small abdominal aortic aneurysms. Cochrane Database Syst Rev 2012; 9: CD009536
    PubMedGoogle Scholar
  • 73 Hackam DG, Thiruchelvam D, Redelmeier DA. Angiotensin-converting enzyme inhibitors and aortic rupture: A population-based case-control study. Lancet 2006; 368: 659-665 . 10.1016/S0140–6736(06)69250–7
    CrossrefPubMedGoogle Scholar
  • 74 Miyake T, Morishita R. Pharmacological treatment of abdominal aortic aneurysm. Cardiovasc Res 2009; 83: 436-443 . 10.1093/cvr/cvp155
    CrossrefPubMedGoogle Scholar
  • 75 Malas MB, Freischlag JA. Interpretation of the results of OVER in the context of EVAR trial, DREAM, and the EUROSTAR registry. Semin Vasc Surg 2010; 23: 165-169 . 10.1053/j.semvascsurg.2010.05.009
    CrossrefPubMedGoogle Scholar
  • 76 Holt PJ, Karthikesalingam A, Patterson BO, Ghatwary T, Hinchliffe RJ, Loftus IM, Thompson MM. Aortic rupture and sac expansion after endovascular repair of abdominal aortic aneurysm. Br J Surg 2012; 99: 1657-1664 . 10.1002/bjs.8938
    CrossrefPubMedGoogle Scholar
  • 77 Prenner SB, Turnbull IC, Malik R, Salloum A, Ellozy SH, Vouyouka AG. , et al. Outcome of elective endovascular abdominal aortic aneurysm repair in octogenarians and nonagenarians. J Vasc Surg 2010; 51: 1354-1359 . 10.1016/j.jvs.2010.01.030
    CrossrefPubMedGoogle Scholar
  • 78 Chadi SA, Rowe BW, Vogt KN, Novick TV, Harris JR, Derose G, Forbes TL. Trends in management of abdominal aortic aneurysms. J Vasc Surg 2012; 55: 924-928 . 10.1016/j.jvs.2011.10.094
    CrossrefPubMedGoogle Scholar
  • 79 Kent KC, Crenshaw ML, Goh DL, Dietz HC. Genotype-phenotype correlation in patients with bicuspid aortic valve and aneurysm. J Thorac Cardiovasc Surg. 2012 Published before print October 24, 2012. 10.1016/j.jtcvs.2012.09.060. Available at: http://www.jtcvsonline.org/article/S0022–5223(12)01214–7/abstract . Accessed April 3, 2013.
    PubMedGoogle Scholar
  • 80 Roberts WC, Ko JM. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation 2005; 111: 920-925 . 10.1161/01.CIR.0000155623.48408.C5
    CrossrefPubMedGoogle Scholar
  • 81 Hinton RB. Bicuspid aortic valve and thoracic aortic aneurysm: Three patient populations, two disease phenotypes, and one shared genotype. Cardiol Res Pract 2012; 2012: 926-975
    PubMedGoogle Scholar
  • 82 Bonderman D, Gharehbaghi-Schnell E, Wollenek G, Maurer G, Baumgartner H, Lang IM. Mechanisms underlying aortic dilatation in congenital aortic valve malformation. Circulation 1999; 99: 2138-2143 . 10.1161/01.CIR.99.16.2138
    CrossrefPubMedGoogle Scholar
  • 83 Kurtovic S, Paloschi V, Folkersen L, Gottfries J, Franco-Cereceda A, Eriksson P. Diverging alternative splicing fingerprints in the transforming growth factor-beta signaling pathway identified in thoracic aortic aneurysms. Mol Med 2011; 17: 665-675
    CrossrefPubMedGoogle Scholar
  • 84 Folkersen L, Wagsater D, Paloschi V, Jackson V, Petrini J, Kurtovic S. , et al. Unraveling divergent gene expression profiles in bicuspid and tricuspid aortic valve patients with thoracic aortic dilatation: The ASAP study. Mol Med 2011; 17: 1365-1373
    CrossrefPubMedGoogle Scholar
  • 85 Ikonomidis JS, Ruddy JM, Benton Jr. SM, Arroyo J, Brinsa TA, Stroud RE. , et al. Aortic dilatation with bicuspid aortic valves: Cusp fusion correlates to matrix metalloproteinases and inhibitors. Ann Thorac Surg 2012; 93: 457-463 . 10.1016/j.athoracsur.2011.09.057
    CrossrefPubMedGoogle Scholar
  • 86 Faggiano E, Antiga L, Puppini G, Quarteroni A, Luciani GB, Vergara C. Helical flows and asymmetry of blood jet in dilated ascending aorta with normally functioning bicuspid valve. Biomech Model Mechanobiol. Published before print October 5, 2012. 10.1007/s10237-012-0444-1. Available at: http://link.springer.com/article/10.1007%2Fs10237-012-0444-1 . Accessed April 3, 2013.
    PubMedGoogle Scholar
  • 87 Barker AJ, Markl M, Burk J, Lorenz R, Bock J, Bauer S. , et al. Bicuspid aortic valve is associated with altered wall shear stress in the ascending aorta. Circ Cardiovasc Imaging 2012; 5: 457-466 . 10.1161/CIRCIMAGING.112.973370
    CrossrefPubMedGoogle Scholar
  • 88 Girdauskas E, Disha K, Raisin HH, Secknus MA, Borger MA, Kuntze T. Risk of late aortic events after an isolated aortic valve replacement for bicuspid aortic valve stenosis with concomitant ascending aortic dilation. Eur J Cardiothorac Surg 2012; 42: 832-838 . 10.1093/ejcts/ezs137
    CrossrefPubMedGoogle Scholar
  • 89 McKellar SH, Michelena HI, Li Z, Schaff HV, Sundt 3rd TM. Long-term risk of aortic events following aortic valve replacement in patients with bicuspid aortic valves. Am J Cardiol 2010; 106: 1626-1633 . 10.1016/j.amjcard.2010.07.043
    CrossrefPubMedGoogle Scholar
  • 90 Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H. , et al. Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg 2012; 42: S1-S44 . 10.1093/ejcts/ezs455
    CrossrefPubMedGoogle Scholar
  • 91 Etz CD, Misfeld M, Borger MA, Luehr M, Strotdrees E, Mohr FW. Current indications for surgical repair in patients with bicuspid aortic valve and ascending aortic ectasia. Cardiol Res Pract 2012; 2012: 313-879
    PubMedGoogle Scholar
  • 92 Price J, De Kerchove L, Glineur D, Vanoverschelde JL, Noirhomme P, El Khoury G. Risk of valve-related events after aortic valve repair. Ann Thorac Surg 2013; 95: 606-612 . 10.1016/j.athoracsur.2012.07.016
    CrossrefPubMedGoogle Scholar
  • 93 Lederle FA, Freischlag JA, Kyriakides TC, Matsumura JS, Padberg Jr. FT, Kohler TR. , et al. Long-term comparison of endovascular and open repair of abdominal aortic aneurysm. N Engl J Med 2012; 367: 1988-1997 . 10.1056/NEJMoa1207481
    CrossrefPubMedGoogle Scholar
  • 94 Sakalihasan N, Hustinx R, Limet R. Contribution of PET scanning to the evaluation of abdominal aortic aneurysm. Semin Vasc Surg 2004; 17: 144-153 . 10.1053/j.semvascsurg.2004.03.002
    CrossrefPubMedGoogle Scholar
  • 95 Sakalihasan N, Michel JB. Functional imaging of atherosclerosis to advance vascular biology. Eur J Vasc Endovasc Surg 2009; 37: 728-734 . 10.1016/j.ejvs.2008.12.024
    CrossrefPubMedGoogle Scholar
  • 96 Xu XY, Borghi A, Nchimi A, Leung J, Gomez P, Cheng Z. , et al. High levels of 18F-FDG uptake in aortic aneurysm wall are associated with high wall stress. Eur J Vasc Endovasc Surg 2010; 39: 295-301 . 10.1016/j.ejvs.2009.10.016
    CrossrefPubMedGoogle Scholar
  • 97 Reeps C, Essler M, Pelisek J, Seidl S, Eckstein HH, Krause BJ. Increased 18F-fluorodeoxyglucose uptake in abdominal aortic aneurysms in positron emission/computed tomography is associated with inflammation, aortic wall instability, and acute symptoms. J Vasc Surg 2008; 48: 417-423 . 10.1016/j.jvs.2008.03.059
    CrossrefPubMedGoogle Scholar
  • 98 Truijers M, Kurvers HA, Bredie SJ, Oyen WJ, Blankensteijn JD. In vivo imaging of abdominal aortic aneurysms: Increased FDG uptake suggests inflammation in the aneurysm wall. J Endovasc Ther 2008; 15: 462-467 . 10.1583/08–2447.1
    CrossrefPubMedGoogle Scholar
  • 99 Defawe OD, Hustinx R, Defraigne JO, Limet R, Sakalihasan N. Distribution of F-18 fluorodeoxyglucose (F-18 FDG) in abdominal aortic aneurysm: High accumulation in macrophages seen on PET imaging and immunohistology. Clin Nucl Med 2005; 30: 340-341 . 10.1097/01.rlu.0000159681.24833.95
    CrossrefPubMedGoogle Scholar
  • 100 Tierney AP, Callanan A, McGloughlin TM. In vivo feasibility case study for evaluating abdominal aortic aneurysm tissue properties and rupture potential using acoustic radiation force impulse imaging. J Mech Behav Biomed Mater 2011; 4: 507-513 . 10.1016/j.jmbbm.2010.12.017
    CrossrefPubMedGoogle Scholar
  • 101 Tierney AP, Callanan A, McGloughlin TM. Use of regional mechanical properties of abdominal aortic aneurysms to advance finite element modeling of rupture risk. J Endovasc Ther 2012; 19: 100-114 . 10.1583/11–3456.1
    CrossrefPubMedGoogle Scholar
  • 102 Tierney AP, Dumont DM, Callanan A, Trahey GE, McGloughlin TM. Acoustic radiation force impulse imaging on ex vivo abdominal aortic aneurysm model. Ultrasound Med Biol 2010; 36: 821-832 . 10.1016/j.ultrasmedbio.2010.02.018
    CrossrefPubMedGoogle Scholar
  • 103 Martufi G, Auer M, Roy J, Swedenborg J, Sakalihasan N, Panuccio G, Gasser CT. Growth of small abdominal aortic aneurysms: A multidimensional approach. J Vasc Surg. In press.
    PubMedGoogle Scholar